JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

The natural history of aortic stenosis in adults.

Accepted clinical views about the natural history of aortic stenosis are based on surprisingly little hemodynamically documented data, and further information in unlikely to be forthcoming in the modern surgical era. Therefore, follow-up data were obtained on 42 adult patients with isolated valvular aortic stenosis catheterized at Georgetown University Hospital who did not undergo early valve replacement. Of 32 symptomatic patients, 23 had moderate or severe stenosis and were followed until death or for an average of 64.4 months after catheterization. The prognosis was more ominous than previously reported. Mortality rates from onset of symptoms were 26% at one year, 48% at two years, and 57% at three years. Fifty-six % of deaths occurred suddenly, within hours of new symptoms. Asymptomatic patients with moderate or severe stenosis did not share the high mortality rate of those with symptoms. Eight such patients were followed for an average of 69.8 months, and none died.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app